Applied Molecular Transport Inc. (AMTI) stock declined over -25.64% intraday to trade at $2.32 a share on NASDAQ. The stock opened with a loss of -19.16% at $1.98 and touched an intraday high of $2.56, falling -25.64% against the last close of $3.12. The stock went to a low of $1.97 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It is also involved in developing AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase Ia clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.
Applied Molecular Transport Inc. (NASDAQ: AMTI) stock price is $2.32 as of the last check on Wednesday, July 6. During the trading session, AMTI stock reached the peak price of $2.56 while $1.97 was the lowest point it dropped to.
The NASDAQ listed AMTI is part of Biotechnology industry that operates in the broader Health Care sector. Applied Molecular Transport Inc. , a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases.
Ms. Elizabeth P. Bhatt M.B.A.
Chief Bus. & Strategy Officer
Mr. Brandon Hants
Sr. VP of Fin. & Bus. Operations and Principal Accounting Officer
Mr. Graham K. Cooper
Dr. Tahir Mahmood Ph.D.
Co-Founder, CEO & Director
AMTI stock traded closed the last session at $2.32, which is $-0.80 or -25.64% lower than its previous close of $3.12. AMTI's current trading price is -13.11% lower than its 52-week high of $46.49 where as its distance from 52-week low of 2.67% is -95.01%.
Number of AMTI employees currently stands at -. AMTI operates from 450 East Jamie Court, South San Francisco, CA 94080, United States.
Official Webiste of $AMTI is: https://www.appliedmt.com
AMTI stock volume for the day was 4,596,012 shares while in the previous session number of AMTI shares traded was 4,594,489 . The average number of AMTI shares traded daily for last 3 months was 352.83 Thousands.
The percentage change in AMTI stock occurred in the recent session was -25.64% while the dollar amount for the price change in AMTI stock was $-0.80.
In the recent session, the day high for AMTI stock was $2.56 while the low for AMTI stock touched on the day was $1.97.
The market value of AMTI currently stands at 89.99 Million with its latest stock price at $2.32 and 38.64 Million of its shares outstanding.